POZ - June #145 : Starting to Gel - by Kellee Terrell
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Sergeant Ozzy Ramos Comes Home

A Tale of Two Cities




Bones: An Owner’s Guide

CD4 Recipe

Hey, Babies

Starting to Gel

Yes, yes, nano

The Truth About Cats

Gut Check

Hep to Weed

Slam Dunk

Prezista Press

Deep Breath

Lives on the Line

Spot Check

Separated at Birth




Hipper Hop

Flesh for Fantasy

Mixed Doubles

Hall Monitor

Moral Minority

From Roger With Love

Red Ribbons and Checkered Flags

Sunday School AIDS

Mayors Get Testy

POZ/NEG-June 2008

Oh, Brother

The Insiders




Editor's Letter-June 2008

Mailbox-June 2008



 
Most Talked About

Has George W. Bush “Done More” to Fight AIDS Than Any Other President? (22)

Does Undetectable Equal Uninfectious? (21)

Are Millions Becoming HIV Positive Because Of ACT UP Paris? (Blog) (21)

Service Interruption: Jeremiah Johnson (12)

Stealing HIV Meds to Mix With Marijuana (11)

Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)


Scroll down to comment on this story.


emailrssprint

June 2008


Starting to Gel

by Kellee Terrell

For positive people, an effective microbicide gel, applied vaginally or rectally to prevent HIV transmission, could one day reduce reliance on condoms. While two earlier microbicides proved ineffective, recent results from a three-year trial of Carraguard—a seaweed-based gel—offer both hope and disappointment:

  • Carraguard was labeled “ineffective [in] blocking HIV transmission”: Among women who used the gel, there were 134 new infections, compared to 151 for those using the placebo.
  • Only 10 percent of participants used Carraguard during sex every single time, though, so the results may stem from poor adherence. Researchers plan to redesign trials to account for personal behavior.
  • Carraguard was proved to be safe on women’s genital surfaces—unlike some other microbicides, which damaged vaginal tissue, making it easier for HIV to penetrate. So Carraguard may provide a base for more potent HIV-preventing compounds in the future.

Search: women, HIV, microbicides , clinical trials


NEW! Scroll down to comment on this story.

emailrssprint


Name: (2-50 characters)
Email: (will not show)
City: (optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

         

[Go to top]
Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Should it be mandatory for couples to receive HIV tests before getting married?
Yes
No

Monthly Poll
Question: Is the Latino community excluded  from conversations about the domestic AIDS crisis?
Yes
No

Surveys
Tell us about your pets.

Do you use social-networking sites?

more surveys  
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy